Literature DB >> 2857992

Nocturnal doses of H2 receptor antagonists for duodenal ulcer.

C W Howden, D B Jones, R H Hunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857992     DOI: 10.1016/s0140-6736(85)92196-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Omeprazole in H2 blocker non-responders.

Authors:  V Savarino; G Mela; A Sumberaz; G Celle
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

3.  A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in gastric ulcer healing.

Authors:  W Rösch
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Roxatidine acetate in the long term maintenance of duodenal ulcers.

Authors:  G Brunner
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.

Authors:  E Hentschel; K Schütze
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.

Authors:  M Deakin; J Ramage; A Paul; S P Gray; J Billings; J G Williams
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

7.  A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.

Authors:  V Savarino; G S Mela; P Scalabrini; G Fera; P Zentilin; A Sumberaz; G Celle
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Resistant duodenal ulcer: when, why and what to do?

Authors:  R P Walt; T K Daneshmend
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401

9.  Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.

Authors:  J A Wilson; D A Johnston; J Penston; K G Wormsley
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

10.  Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.

Authors:  M Deakin; H P Glenny; J K Ramage; J G Mills; W L Burland; J G Williams
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.